NCT00912340 - Phase II Trial of EVEROLIMUS ± Trastuzumab in Hormone-Refractory Metastatic Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions

Breast Cancer

Interventions

DRUG

Everolimus

BIOLOGICAL

Trastuzumab

Trial Locations (4)

Emory University Hospital Midtown, Atlanta

Emory University Winship Cancer Institute, Atlanta

University of Wisconsin Carbone Cancer Center, Madison

Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago